DOES LATE GADOLINIUM ENHANCEMENT IDENTIFY THE PATIENTS AT RISK IN CHILDHOOD HYPERTROPHIC CARDIOMYOPATHY? A MULTICENTER STUDY

Cardiovascular magnetic resonance (CMR) with late gadolinium enhancement (LGE) has emerged as a potential marker for risk of adverse events in adult patients with hypertrophic cardiomyopathy (HCM). However, previous studies of pediatric patients have been limited to small cohorts with short follow-up periods and therefore the clinical significance of LGE in the pediatric HCM population remains uncertain. The aims of this study were 1) to...